Engineering Live Biotherapeutics to Expose Antigens or Deliver Therapeutic Agents to Treat Complex Respiratory Diseases
Time: 12:00 pm
day: Focus Day
Details:
- Utilising a unique genetic toolkit to engineer the genome of a minimal cell lung bacteria, MycoChassis
- Developing a pipeline of products to treat diseases that require the combination of different MoAs
- Outlining pre-clinical results showing efficacy and safety for both biofilm associated infections pipeline as well as lead product designed to treat non-small cell lung carcinoma (NSCLC) patients that don’t respond to immunotherapy
